Brief: Medreleaf Corp Enters Agreement With BioPharma Services To Conduct Clinical Research For Cannabis
29/05/2018 12:14
May 29 (Reuters) - MedReleaf Corp LEAF.TO :
* MEDRELEAF CORP - ENTERED INTO AN EXCLUSIVE AGREEMENT WITH
BIOPHARMA SERVICES TO CONDUCT CLINICAL RESEARCH FOR CANNABIS AND
CANNABIS DERIVED PRODUCTS
* MEDRELEAF CORP - UNDER AGREEMENT BIOPHARMA WILL BECOME AN
EXTENSION OF MEDRELEAF'S CLINIC DEVELOPMENT TEAM
Source text for Eikon: ID:nCNWw1wzWa
Further company coverage: LEAF.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on East Side Games
See all newsCanada's East Side Games Q1 revenue falls 32% as user acquisition spending drops
Canada's East Side Games Q4 revenue declines on tough competition, high platform fees
Canada's East Side Games Q3 revenue misses expectations
Brief: East Side Games Q2 Revenue CAD 19.2 Million
Brief: East Side Games Group Reports Fourth Quarter 2023 Financial Results